Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Veracyte reported $26.23M in Cost of Sales for its fiscal quarter ending in March of 2023.

Cost Of Sales Change
Agenus AGEN:US USD 2.29M 5.4M
Agilent A:US USD 793M 5M
Anika Therapeutics ANIK:US USD 15.08M 410K
Bruker BRKR:US USD 325.6M 17.2M
Exact Sciences EXAS:US USD 156.87M 9.71M
Heron Therapeutics HRTX:US USD 16.85M 4.23M
Illumina ILMN:US USD 432M 21M
Immunogen IMGN:US USD 626K 450K
Karyopharm Therapeutics KPTI:US USD 1.35M 517K
Laboratory Of America LH:US USD 2.8B 98.8M
Ligand Pharmaceuticals LGND:US USD 3.72M 17.9M
Myriad Genetics MYGN:US USD 59.2M 5.3M
Rigel Pharmaceuticals RIGL:US USD 977K 635K
Roche Holding ROG:VX CHF 8.95B 613M
Siemens SIE:GR EUR 12.22B 1.11B
Sonic Healthcare SHL:AU AUD 622.48M 171.02M
Thermo Fisher Scientific TMO:US USD 6.44B 278M
Veracyte VCYT:US USD 26.23M 602K
Waters WAT:US USD 284.38M 63.81M